| John Porterfield, | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (800) 822-8816 | |
| Not Available |
| Full Name | John Porterfield |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 22 Years |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811977986 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 28795 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
"The World Bank on Thursday named David Wilson, a Zimbabwean national who has written extensively about AIDS in the developing world, to head the poverty-fighting institution's global HIV/AIDS program," Reuters reports.
A team of neuroscientists has identified a protein in laboratory mice linked to impairments similar to those afflicted with Angelman syndrome (AS)—a condition associated with symptoms that include autism, intellectual disability, and motor abnormalities.
› Verified 9 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
"The World Bank on Thursday named David Wilson, a Zimbabwean national who has written extensively about AIDS in the developing world, to head the poverty-fighting institution's global HIV/AIDS program," Reuters reports.
A team of neuroscientists has identified a protein in laboratory mice linked to impairments similar to those afflicted with Angelman syndrome (AS)—a condition associated with symptoms that include autism, intellectual disability, and motor abnormalities.
› Verified 9 days ago
| Entity Name | The Russell Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417252537 PECOS PAC ID: 6406754431 Enrollment ID: O20110307000502 |
News Archive
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
"The World Bank on Thursday named David Wilson, a Zimbabwean national who has written extensively about AIDS in the developing world, to head the poverty-fighting institution's global HIV/AIDS program," Reuters reports.
A team of neuroscientists has identified a protein in laboratory mice linked to impairments similar to those afflicted with Angelman syndrome (AS)—a condition associated with symptoms that include autism, intellectual disability, and motor abnormalities.
› Verified 9 days ago
| Entity Name | Lv Stabler Primary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871003533 PECOS PAC ID: 7719246586 Enrollment ID: O20180124002028 |
News Archive
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
"The World Bank on Thursday named David Wilson, a Zimbabwean national who has written extensively about AIDS in the developing world, to head the poverty-fighting institution's global HIV/AIDS program," Reuters reports.
A team of neuroscientists has identified a protein in laboratory mice linked to impairments similar to those afflicted with Angelman syndrome (AS)—a condition associated with symptoms that include autism, intellectual disability, and motor abnormalities.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Porterfield, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | John Porterfield, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
"The World Bank on Thursday named David Wilson, a Zimbabwean national who has written extensively about AIDS in the developing world, to head the poverty-fighting institution's global HIV/AIDS program," Reuters reports.
A team of neuroscientists has identified a protein in laboratory mice linked to impairments similar to those afflicted with Angelman syndrome (AS)—a condition associated with symptoms that include autism, intellectual disability, and motor abnormalities.
› Verified 9 days ago
Melanie Morris, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Rebecca Horst, PA Surgery Medicare: Medicare Enrolled Practice Location: 817 Princeton Ave Sw Ste 306, Birmingham, AL 35211 Phone: 205-783-0160 Fax: 205-788-6249 | |
Timothy Lee Christopher, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3686 Grandview Pkwy Ste 400, Birmingham, AL 35243 Phone: 205-595-8985 Fax: 205-595-8987 | |
Dr. Richard Ira Kirkland, MD Surgery Medicare: Medicare Enrolled Practice Location: 513 Brookwood Blvd, Suite 501, Birmingham, AL 35209 Phone: 205-930-8010 Fax: 205-930-8014 | |
Kyle Stigall, MD Surgery Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35233 Phone: 205-934-4011 | |
Jayme Locke, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Emily Long, MD Surgery Medicare: Medicare Enrolled Practice Location: 50 Medical Park Dr E, Birmingham, AL 35235 Phone: 205-838-3000 |